## **Core Concept**
Anti-mitochondrial antibodies (AMAs) are a type of autoantibody that targets the mitochondria. These antibodies are commonly associated with autoimmune disorders. The primary condition linked to AMAs is Primary Biliary Cholangitis (PBC), a chronic liver disease characterized by the progressive destruction of the bile ducts within the liver.

## **Why the Correct Answer is Right**
The correct answer, **Primary Biliary Cholangitis (PBC)**, is associated with anti-mitochondrial antibodies because AMAs are found in approximately 95% of patients with PBC. These antibodies are directed against the E2 component of the pyruvate dehydrogenase complex (PDC-E2) located on the mitochondrial surface. The presence of AMAs is considered a hallmark serological marker for PBC, aiding in its diagnosis.

## **Why Each Wrong Option is Incorrect**
- **Option A: Rheumatoid Arthritis** - While rheumatoid arthritis is an autoimmune disease, it is primarily associated with rheumatoid factor (RF) and anti-citrullinated protein antibodies (anti-CCP), not anti-mitochondrial antibodies.
- **Option B: Systemic Lupus Erythematosus (SLE)** - SLE is characterized by a wide range of autoantibodies, including anti-nuclear antibodies (ANA), anti-dsDNA, and anti-Sm antibodies, but not typically anti-mitochondrial antibodies.
- **Option C: Primary Sclerosing Cholangitis** - This condition is more commonly associated with anti-neutrophil cytoplasmic antibodies (p-ANCA) rather than anti-mitochondrial antibodies.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the presence of anti-mitochondrial antibodies is highly suggestive of Primary Biliary Cholangitis (PBC), especially in a patient with cholestatic liver enzymes. This association is so strong that AMAs are considered a diagnostic criterion for PBC.

## **Correct Answer: D. Primary Biliary Cholangitis.**